On December 4, 2024, Paul Wotton, a Director at Vericel Corp (VCEL, Financial), sold 2,600 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 27,402 shares of the company.
Vericel Corp (VCEL) is a company that specializes in advanced cell therapies for the sports medicine and severe burn care markets. The company is known for its innovative treatments that aim to improve the lives of patients with serious medical conditions.
Over the past year, Paul Wotton has sold a total of 7,600 shares and has not purchased any shares. The insider transaction history for Vericel Corp shows that there have been 0 insider buys and 41 insider sells over the same timeframe.
On the day of the recent sale, shares of Vericel Corp were trading at $58.72, giving the stock a market cap of $2,789.732 million. The company's price-earnings ratio stands at 807.43, which is higher than the industry median of 26.55 and also higher than the company’s historical median price-earnings ratio.
With a trading price of $58.72 and a GF Value of $45.30, Vericel Corp has a price-to-GF-Value ratio of 1.3, indicating that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
